
Today on Pharmaceutical Processing
GSK invests another $800M in Pennsylvania site expansions
GSK is expanding its footprint in Pennsylvania, with plans to invest $800 million in a biopharma research and manufacturing hub that’s expected to create more than 300 jobs in the next five years. New construction is slated to begin next year at facilities in Upper Merion Township outside Philadelphia, near the drugmaker’s U.S. headquarters —…Getinge Life Science president is leaving
Swedish medtech company Getinge announced today that the president of its Life Science business is resigning to pursue an external opportunity. A veteran of BD, Abbott and Boston Scientific, Eric Honroth joined Getinge eight years ago. He moved up to worldwide president of Life Science in 2022. “We are thankful for Eric’s important contributions to…Sponsored Content See More >
Regulatory See More >

Fujifilm Biotechnologies selected for FDA PreCheck Pilot Program
A Fujifilm Biotechnologies’ commercial-scale cell culture manufacturing facility has been selected for the FDA’s PreCheck Pilot Program, the company announced. The CDMO’s Holly Springs, North Carolina, facility was selected as one of seven participants in the program designed to strengthen United States pharmaceutical manufacturing capabilities and accelerate patient access to critical medicines. “We are honored…
Learn how to rapidly develop smart and sustainable engineering and production processes See More >

Personalized medicine: advanced technology is saving lives
The concept of a “batch size one” in pharmaceutical manufacturing is closer than ever. There are companies advancing cell therapies in which body cells are used to heal or support the individual patient. These cells are manipulated or edited to change certain biological characteristics before being transferred to the patient. Personalized medicine is truly about…
Facility See More >

GSK invests another $800M in Pennsylvania site expansions
GSK is expanding its footprint in Pennsylvania, with plans to invest $800 million in a biopharma research and manufacturing hub that’s expected to create more than 300 jobs in the next five years. New construction is slated to begin next year at facilities in Upper Merion Township outside Philadelphia, near the drugmaker’s U.S. headquarters —…
Supply Chain See More >
Bayer plans to build $2.2B Ohio drug manufacturing site
Bayer plans to put $2.2 billion toward the construction of a new drug production site in Ohio, with a starting focus in oncology, cardiovascular and kidney therapies. Described as a modular campus that will span drug substance and product manufacturing, the site outside Columbus in New Albany is slated to create about 600 new jobs.…
Recalls See More >

Report: Japan health authorities investigate Kobayashi Pharmaceutical factory after five deaths
Japanese health authorities searched a Kobayashi Pharmaceutical factory in Japan following reports of five deaths related to dietary supplements, Reuters reports. The plant inspection in western Japan is the second in recent days as health authorities inspected the company’s Osaka facility. In addition to the five reported deaths, there have been more than 100 hospitalizations…






































